Syllabus
BCPP Prep Course (BCPP)
84 lessons. Online and self-paced.
Assessment Foundations
Core patient assessment skills for psychiatric pharmacy practice, including interview elements, scales, risk identification, and medication-focused evaluation within pharmacist scope.
- 1Psychiatric History Components
- 2Mental Status Exam Findings
- 3Screening And Monitoring Scales
- 4Suicide Risk Red Flags
- 5Mental Health Crisis Presentations
- 6Relapse And Recurrence Risks
- 7Motivational Interviewing Principles
- 8Social Determinants And Access
- 9Adherence Barrier Assessment
- 10Vitals And Physical Findings
- 11Laboratory Monitoring Basics
- 12Medication-Induced Psychiatric Symptoms
Psychopharmacology Principles
Foundational pharmacology, pharmacokinetics, pharmacodynamics, and pharmacogenomics needed to optimize psychiatric medication therapy.
- 13Antidepressant Class Mechanisms
- 14Antipsychotic Receptor Profiles
- 15Mood Stabilizer Pharmacology
- 16Absorption Distribution Metabolism Elimination
- 17CYP And P-Gp Interactions
- 18Therapeutic Drug Monitoring Principles
- 19CYP2D6 And CYP2C19 Testing
- 20HLA And Serious Reactions
- 21Pharmacogenomics In Treatment Selection
Mood And Anxiety Disorders
Evidence-informed medication management for depressive, bipolar, anxiety, trauma-related, and obsessive-compulsive disorders.
- 22Major Depression Pharmacotherapy
- 23Treatment-Resistant Depression Strategies
- 24Switching And Cross-Tapering Antidepressants
- 25Acute Mania Treatment
- 26Bipolar Depression Pharmacotherapy
- 27Maintenance And Relapse Prevention
- 28Generalized Panic And Social Anxiety
- 29PTSD Medication Considerations
- 30Obsessive-Compulsive Disorder Pharmacotherapy
Psychotic Disorders
Treatment and monitoring of schizophrenia-spectrum disorders, antipsychotic use, long-acting injectables, and refractory illness.
- 31First-Episode Antipsychotic Selection
- 32Acute Psychosis And Agitation
- 33Maintenance Adherence Strategies
- 34Treatment-Resistant Schizophrenia Criteria
- 35Clozapine Initiation And Titration
- 36Clozapine Monitoring And Toxicity
- 37LAI Product Fundamentals
- 38Oral To LAI Conversions
- 39LAI Selection In Practice
Substance Use Disorders
Medication management of alcohol, opioid, nicotine, and other substance-related conditions, including withdrawal and toxicology principles.
- 40Alcohol Withdrawal Recognition
- 41Alcohol Withdrawal Pharmacotherapy
- 42Relapse Prevention Medications
- 43Buprenorphine And Methadone Basics
- 44Naltrexone And Opioid Transitions
- 45Naloxone And Harm Reduction
- 46Tobacco Cessation Pharmacotherapy
- 47Sedative And Stimulant Withdrawal
- 48Substance-Induced Symptom Patterns
Special Populations
Psychiatric pharmacotherapy considerations in children, older adults, pregnancy, lactation, and medically complex populations.
- 49ADHD Pharmacotherapy Principles
- 50Youth Depression And Bipolar Risks
- 51Neurodevelopmental Disorder Medications
- 52Late-Life Depression And Anxiety
- 53Dementia-Related Behavioral Symptoms
- 54Parkinsonism Seizures And Headache
- 55Pregnancy Risk-Benefit Principles
- 56Lactation Medication Considerations
- 57Renal Hepatic And Cardiac Factors
Adverse Effects And Safety
Recognition, prevention, and management of psychotropic adverse effects, toxicity syndromes, and high-risk interactions.
- 58Metabolic Monitoring And Management
- 59EPS And Tardive Syndromes
- 60Prolactin Sexual And Sedation Effects
- 61Serotonin Syndrome Recognition
- 62Neuroleptic Malignant Syndrome
- 63Rash Blood Dyscrasias And Organ Toxicity
- 64QT Risk And ECG Factors
- 65Contraindications And Warning Traps
- 66Psychotropic Deprescribing Strategies
Clinical Calculations And Monitoring
Quantitative and interpretation skills for dose adjustment, conversions, titrations, and patient-specific monitoring decisions.
- 67Renal Dose Adjustment Rules
- 68Hepatic And Elderly Dosing
- 69Formulation And Schedule Conversions
- 70Lithium Level Interpretation
- 71Valproate And Carbamazepine Levels
- 72Clozapine Concentration Applications
- 73Medication Optimization Framework
- 74Monitoring Plan Construction
- 75Dose Conversion Case Traps
Evidence And Practice Management
Evidence appraisal, patient education, documentation, policy, and systems-based psychiatric pharmacy practice for BCPP preparation.
- 76Guidelines Trials And References
- 77Study Design And Bias
- 78Statistics And Clinical Applicability
- 79Counseling And Teach-Back
- 80Documentation Best Practices
- 81Interprofessional And Transitional Care
- 82Quality Measures And Safety Systems
- 83Formulary Economics And Reimbursement
- 84Advocacy Resources And Practice Models


